Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.23−0.03 (-10.27%)
Close on Nov 17, 2026Market cap $3.59MP/E –Yield –
Traws Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Traws Pharma's price to sales ratio was 4.6× on Apr 30, 2026, against 23.4× a year earlier. Over the last 5 years it ranged from 2.8× to 465.3×, with a median of 69.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 4.6× | +1.8 |
| 2025 | Dec 31, 2025 | 2.8× | −116.0 |
| 2024 | Dec 31, 2024 | 118.9× | +49.6 |
| 2023 | Dec 29, 2023 | 69.3× | +9.1 |
| 2022 | Dec 30, 2022 | 60.2× | −174.5 |
| 2021 | Dec 31, 2021 | 234.7× | −190.5 |
| 2020 | Dec 31, 2020 | 425.2× | +423.8 |
| 2019 | Dec 31, 2019 | 1.4× | −7.7 |
| 2018 | Dec 31, 2018 | 9.1× | −9.0 |
| 2017 | Dec 29, 2017 | 18.1× | +17.1 |
| 2016 | Dec 30, 2016 | 1.0× | −10.5 |
| 2015 | Dec 31, 2015 | 11.5× | −15.8 |
| 2014 | Dec 31, 2014 | 27.3× | −15.2 |
| 2013 | Dec 31, 2013 | 42.5× | – |
See a number that looks wrong?